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Background: To determine the association of 
tobacco smoking (whether active or passive) with 
hyperthyroidism, in patients presenting to the three 
tertiary health care facilities of Rawalpindi. 
Methods: A case-control study was conducted from 
1st December 2014 to 1st December 2017 at three 
tertiary care hospitals of Rawalpindi. 810 individuals 
were included in the study. 648 were established 
cases of euthyroid status. The other 162 were selected 
on the basis of their presenting signs and symptoms, 
established diagnoses of hyperthyroidism and 
decreased levels of thyroid stimulating hormone 
(TSH). Visits were made to surgical and medical 
ward patients whose state of health placed them in 
inclusion criteria, and detailed history was recorded 
for each individual. History included detailed 
questioning about personal habits, smoking of 
tobacco (whether done actively or passively), 
chewing of tobacco and specific questions that 
focused on exclusion criteria. A person consuming 1 
pack of cigarettes per day/directly or exposed to the 
smoke of equivalent amounts of tobacco was 
labelled as actively-exposed.  
Results: Among 162 cases, 58 (36.25%) individuals 
were either active or passive smokers prior to 
diagnosis of hyperthyroidism. In 648 euthyroid 
individuals, 97 (14.96%) were found to be active or 
passive smokers. OR = 3.17, 95% CI = 0.347 to 0.414, 
P-value = <0.0001. Tobacco smokers/chewers were 
3.17 times more likely to develop hyperthyroidism 
than non-tobacco users.  
Conclusion: Tobacco smoking is positively 
associated with likelihood of occurrence of 
hyperthyroidism. 
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Introduction 
Thyroid gland is one of the most important endocrine 
glands of the human body, producing hormones 
which play key roles in growth and metabolism.1,2 
Thyroid disorders are becoming increasingly 
common3. Hyperthyroidism can be a result of Graves’ 
disease, toxic multi-nodular goitre, iodine excess, 
carcinomas, ovarian tumours and excess exogenous 
administration of thyroid hormones.1  
Tobacco smoking has profound effects on the thyroid 
gland, but these effects are incompletely understood4. 
There are numerous components in tobacco smoke, 
and it is difficult to ascertain which of these is 
influencing the thyroid gland.5 It is likely that 
thiocyanate of smoke inhibits iodide transport in the 
thyroid gland, and thus inhibits thyroid hormone 
synthesis.6 
According to a statistical research carried out by 
American Thyroid Association (A.T.A), more than 12% 
of U.S population will develop an over or underactive 
thyroid condition, at least once, over the course of 
their lifetimes.7 Such high prevalence might be traced 
to higher smoking rate in US population (An estimated 
15% of whole population smokes tobacco cigarettes).8 
Prevalence of cigarette smoking (active/passive) ratio 
in Pakistan is much higher than United States 
(approximately 21% people indulge in smoking 
tobacco in a variety of forms)9, and it can be expected 
that the prevalence of hyperthyroidism can 
proportionally be higher as well.  
Rationale of this study is to establish an association 
between tobacco smoke and thyroid disorders, with 
tobacco smoking as a risk factor, particularly for 
hyperthyroidism. Individuals who are predisposed to 
hyperthyroidism (iodine-induced hyperthyroidism10; 
with past medical or surgical history of pathological 
thyroid gland; DMT-111) can thus be directed for 
precaution. Since Pakistan is one of the biggest 
consumers of tobacco, general population of Pakistan 
is very likely to benefit from the outcomes of this 
research, which is trying to prove a relationship 
between tobacco use and a particularly endangering 
and impairing endocrine disease.  
 
 
Journal of Rawalpindi Medical College; 2019;23(S-1): 34-36 
35 
 
Materials and Methods 
A case-control study was conducted at three tertiary 
healthcare hospitals in Rawalpindi from 1st December 
2014 to 1st December 2017. The names of these 
hospitals are: Holy Family Hospital, Benazir Bhutto 
Hospital, and District Headquarters Hospital. 
A sample size of 810 was calculated for this case-
control study, with 1:4 ratio i.e 1 case for every 4 
controls. The formula applied was: 
n = [{(r + 1)/r} x {(p*) (1-p*) (Zβ + Zα/2)2 / (p1 – p2)2}] 
n is the sample size (= 810) 
r is the ratio of control to cases (= 4/1) 
p* is the average proportion exposed (= 0.675) 
Zβ + Zα/2   is the standard normal variate for power 
minus standard normal variate for level of significance 
(= 0.84 + 1.96 = 2.71). p1 – p2 is the expected difference 
in proportion of cases and controls (estimated 0.400 – 
0.355) 4  
Therefore, 810 people were included in the study, of 
which 162 individuals were established cases of 
hyperthyroidism and 648 individuals were controls of 
euthyroid status. They were clustered in these two 
categories on the basis of levels of their TSH levels.  
Visits were made to surgical and medical ward 
patients whose state of health placed them in inclusion 
criteria for case group, and detailed history was 
recorded for each individual.  
History included questioning about personal habits, 
especially smoking/chewing tobacco, whether actively 
done or passively. Persons who consumed 1 pack of 
cigarettes (or chewed an equivalent amount) per day 
were marked as actively-exposed. Those who were 
exposed to smoke of 1 pack of cigarettes smoked daily 
were considered to be passive smokers.  
A case-control ratio of 1:4 was followed, with 
enrolment of 4 controls for every 1 case. Controls were 
selected from the neighbouring beds. They were 
selected on the basis of their physical examination. 
Their euthyroid status was positively confirmed 
through biochemical evaluation of serum TSH levels.  
Case group inclusion criteria: Individuals with TSH 
level <0.40 mIU/L 
Control group inclusion criteria: Individuals with TSH 
level = 0.45 – 4.5 mIU/L 
Exclusion criteria: Above the age of 70 years12, 
autoimmune disease affected, familial predisposition 
to hyperthyroidism13, pregnancy, alcohol abuser, 
exposure to hazardous chemicals in industry 
(according to occupational history). 
Approval was sought from the Ethical Committee of 
Rawalpindi Medical University. After informed 
consent, a detailed history was taken from all 
participants. They were ensured confidentiality. 
Questions were asked considering the ethical 
considerations and secrecy of personal identity. They 
were inquired regarding their smoking habits, whether 
they used tobacco, or they were exposed to it from a 
close contact; familial disposition to hyperthyroidism, 
alcohol consumption, and pregnancy.  Their detailed 
history also focused on their occupations and 
socioeconomic status.  
The data was entered with SPSS version 23 and 
descriptive analysis was performed.  
 
Results 
Over the time period of 3 years, 162 cases of 
hyperthyroidism were chosen and scrutinized. Of 
these, 58 (36.25%) were actively/passively exposed to 
the tobacco constituents. Of the 648 controls, 97 
(14.96%) were actively/passively exposed (TABLE I). 
An odds ratio of 3.17 was calculated, with 95% CI = 
0.347 to 0.414. The p-value was <0.0001 meaning that 
our results are statistically significant. There was a 
significant association between smoking and the 
development of hyperthyroidism. 
TSH levels were measured for all the participants of 
the study (TABLE II). It was found that 648 (80.05%) 
people had normal TSH levels (0.45 – 4.5 m IU/L) 
while 162 (19.95%) had decreased TSH levels (0.01 – 
0.40). This evaluation of TSH was used to distinguish 
cases and controls.  
 
Table I - Standard 2x2 contingency table of 
hyperthyroidism coexistence with tobacco smoking 
exposure 
 Cases Controls 
Exposed 58 97 
Not Exposed 104 551 
Total 162 648 
 
Table II– TSH levels of the cases and controls 
TSH Levels (m 
IU/L) 
Frequency Percentage 
0.01 – 0.40 162 19.95 
0.45 – 4.5 648 80.05 
Total 810 100.0 
 
Discussion 
In countries like Pakistan, where education is 
uncommon, it is unsurprising to find that tobacco 
smoking is prevalent9. We found that tobacco smoking 
is a risk factor for developing hyperthyroidism. The 
Odds Ratio was 3.17, meaning that the odds of 
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smokers developing hyperthyroidism were 3.17 times 
higher than the odds of non-smokers developing 
hyperthyroidism. 
This result can be used for the purpose of persuading 
those at risk of developing hyperthyroidism into 
quitting the habit of smoking. It also has other clinical 
and research implications, including biochemical 
exploration of the constituents that make tobacco a risk 
factor for hyperthyroidism.  
A cross-sectional study funded by the HUNT Research 
Centre in Norway concluded that tobacco smoking is 
positively associated with hyperthyroidism4. The 
HUNT study reported an OR of 3.17 for overt 
hyperthyroidism in current smokers as compared to 
never smokers. The value exactly matches the one 
which we obtained in our study. The HUNT study also 
reported that the greater the number of cigarettes 
smoked per day, the lower the mean plasma 
thyrotropin levels4. 
Using the Nurses’ Health Study II as a basis, 
researches in Boston discovered that tobacco smoking 
was a risk factor for Graves’ hyperthyroidism, while 
alcohol intake and physical activity played no role in 
the development of the disease14. The hazards ratio 
among current smokers was 1.93. 
It is likely that reducing the prevalence of tobacco 
smoking will reduce the incidence of hyperthyroidism 
in the country. There is need for awareness and 
education, and the general population should be 
strictly discouraged from tobacco smoking. 
 
Conclusion 
Smoking is significantly associated with the risk of 
developing state of hyperthyroidism 
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